tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CDTX Stock Latest News

Cidara Therapeutics price target raised to $35 from $31 at RBC Capital
The FlyCidara Therapeutics price target raised to $35 from $31 at RBC Capital
1d ago
CDTX
Cidara Therapeutics price target raised to $50 from $35 at Guggenheim
PremiumThe Fly
Cidara Therapeutics price target raised to $50 from $35 at Guggenheim
8d ago
CDTX
Promising Developments and Upcoming Data Release Drive Buy Rating for Cidara Therapeutics
PremiumRatings
Promising Developments and Upcoming Data Release Drive Buy Rating for Cidara Therapeutics
9d ago
CDTX
Cidara Therapeutics’ CD388 Progress and Challenges Highlighted in Earnings Call
PremiumCompany Announcements
Cidara Therapeutics’ CD388 Progress and Challenges Highlighted in Earnings Call
15d ago
CDTX
Cidara Therapeutics price target raised to $35 from $33 at Guggenheim
PremiumThe Fly
Cidara Therapeutics price target raised to $35 from $33 at Guggenheim
15d ago
CDTX
Promising Outlook for Cidara Therapeutics: Buy Rating Affirmed Amid Upcoming R&D Insights and Strategic FDA Engagement
PremiumRatingsPromising Outlook for Cidara Therapeutics: Buy Rating Affirmed Amid Upcoming R&D Insights and Strategic FDA Engagement
15d ago
CDTX
Cidara Therapeutics price target raised to $47 from $46 at Citizens JMP
Premium
The Fly
Cidara Therapeutics price target raised to $47 from $46 at Citizens JMP
15d ago
CDTX
Cidara Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Cidara Therapeutics Reports Q1 2025 Financial Results
16d ago
CDTX
Cidara Therapeutics reports Q1 EPS ($1.66) vs. ($2.28) last year
PremiumThe Fly
Cidara Therapeutics reports Q1 EPS ($1.66) vs. ($2.28) last year
16d ago
CDTX
Cidara Therapeutics files $500M mixed securities shelf
PremiumThe Fly
Cidara Therapeutics files $500M mixed securities shelf
16d ago
CDTX
Cidara Therapeutics Inc. (CDTX) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Cidara Therapeutics Inc. (CDTX) Q1 Earnings Cheat Sheet
18d ago
CDTX
Cidara Therapeutics management to meet virtually with Needham
PremiumThe Fly
Cidara Therapeutics management to meet virtually with Needham
19d ago
CDTX
Cidara Therapeutics announces promotion of Davarpanah to CMO
PremiumThe FlyCidara Therapeutics announces promotion of Davarpanah to CMO
23d ago
CDTX
Elicio Therapeutics appoints Preetam Shah as chief strategy, financial officer
Premium
The Fly
Elicio Therapeutics appoints Preetam Shah as chief strategy, financial officer
2M ago
CDTX
ELTX
Positive Buy Rating for Cidara Therapeutics Driven by Promising CD388 Development and Safety Profile
Premium
Ratings
Positive Buy Rating for Cidara Therapeutics Driven by Promising CD388 Development and Safety Profile
2M ago
CDTX
Cidara Therapeutics to present on CD388 at ICAR 2025
PremiumThe Fly
Cidara Therapeutics to present on CD388 at ICAR 2025
2M ago
CDTX
Cidara Therapeutics: CD388 preclinical data published in Nature Microbiology
PremiumThe Fly
Cidara Therapeutics: CD388 preclinical data published in Nature Microbiology
2M ago
CDTX
Cidara Therapeutics initiated with an Outperform at Citizens JMP
PremiumThe Fly
Cidara Therapeutics initiated with an Outperform at Citizens JMP
2M ago
CDTX
Buy Rating for Cidara Therapeutics: Promising Potential of CD388 in Influenza Prevention
PremiumRatings
Buy Rating for Cidara Therapeutics: Promising Potential of CD388 in Influenza Prevention
2M ago
CDTX
Ed Arce’s Buy Rating for Cidara Therapeutics Driven by Accelerated CD388 Program and Promising Phase 2b NAVIGATE Study Developments
PremiumRatingsEd Arce’s Buy Rating for Cidara Therapeutics Driven by Accelerated CD388 Program and Promising Phase 2b NAVIGATE Study Developments
3M ago
CDTX
Cidara Therapeutics price target raised to $35 from $24 at H.C. Wainwright
Premium
The Fly
Cidara Therapeutics price target raised to $35 from $24 at H.C. Wainwright
3M ago
CDTX
Cidara Therapeutics Faces Financial Risks Amid Delayed Annual Report Filing
Premium
Company Announcements
Cidara Therapeutics Faces Financial Risks Amid Delayed Annual Report Filing
3M ago
CDTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >